IMP
Process View
endothelial cell migration
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "endothelial cell migration"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FN1 | fibronectin 1 | 1.000 | Zebrafish | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | Human | |
| EGFR | epidermal growth factor receptor | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 0.998 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.997 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.996 | ||
| SFN | stratifin | 0.996 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.996 | Human | |
| YAP1 | Yes-associated protein 1 | 0.994 | ||
| JAG1 | jagged 1 | 0.994 | Human | |
| S100B | S100 calcium binding protein B | 0.986 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.984 | Human | |
| S100A6 | S100 calcium binding protein A6 | 0.978 | Human | |
| NRP1 | neuropilin 1 | 0.978 | ||
| S100A11 | S100 calcium binding protein A11 | 0.977 | Human | |
| LAT | linker for activation of T cells | 0.973 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.967 | Human | |
| JUN | jun proto-oncogene | 0.963 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.958 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.956 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.953 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.952 | Human | |
| ZYX | zyxin | 0.950 | ||
| RARA | retinoic acid receptor, alpha | 0.942 | ||
| ANXA1 | annexin A1 | 0.940 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.937 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.932 | Mouse | |
| NOTCH1 | notch 1 | 0.924 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.924 | ||
| THBS1 | thrombospondin 1 | 0.922 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.918 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.916 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.909 | Human | |
| ENG | endoglin | 0.906 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.893 | ||
| FGA | fibrinogen alpha chain | 0.891 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.888 | ||
| S100A8 | S100 calcium binding protein A8 | 0.887 | Human | |
| FBLN1 | fibulin 1 | 0.887 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.860 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.858 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.851 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.840 | ||
| EGR1 | early growth response 1 | 0.832 | Human | |
| HSPB8 | heat shock 22kDa protein 8 | 0.830 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.827 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.823 | ||
| FLNA | filamin A, alpha | 0.819 | ||
| EMP3 | epithelial membrane protein 3 | 0.813 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.813 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.797 | ||
| SMAD3 | SMAD family member 3 | 0.789 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.785 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.784 | Zebrafish | |
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.778 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.772 | ||
| S100A14 | S100 calcium binding protein A14 | 0.771 | Human | |
| TPM4 | tropomyosin 4 | 0.771 | ||
| ANXA2 | annexin A2 | 0.769 | ||
| CTGF | connective tissue growth factor | 0.766 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.764 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.760 | ||
| EGR3 | early growth response 3 | 0.748 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.745 | ||
| CRYAB | crystallin, alpha B | 0.736 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.734 | ||
| S100A4 | S100 calcium binding protein A4 | 0.732 | Human | |
| S100A1 | S100 calcium binding protein A1 | 0.696 | Human | |
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.695 | ||
| PRKCA | protein kinase C, alpha | 0.694 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.687 | ||
| BMP2 | bone morphogenetic protein 2 | 0.684 | Human | |
| LMNA | lamin A/C | 0.676 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.675 | ||
| PPL | periplakin | 0.671 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.665 | ||
| KLK10 | kallikrein-related peptidase 10 | 0.651 | Human | |
| NOTCH3 | notch 3 | 0.648 | Human | |
| NOSTRIN | nitric oxide synthase trafficker | 0.644 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.641 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.611 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.601 | ||
| VIM | vimentin | 0.574 | ||
| S100A16 | S100 calcium binding protein A16 | 0.565 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.557 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.553 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.552 | Human | |
| NCOR2 | nuclear receptor corepressor 2 | 0.532 | ||
| S100A9 | S100 calcium binding protein A9 | 0.519 | Human | |
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.506 | ||
| PDGFC | platelet derived growth factor C | 0.505 | ||
| KLF6 | Kruppel-like factor 6 | 0.499 | Human | |
| IER2 | immediate early response 2 | 0.494 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.483 | ||
| FSTL1 | follistatin-like 1 | 0.477 | ||
| A2M | alpha-2-macroglobulin | 0.468 | ||
| VEGFC | vascular endothelial growth factor C | 0.458 | Human Rat | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.457 | ||
| JUNB | jun B proto-oncogene | 0.455 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.445 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.444 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.437 | ||
| TLN1 | talin 1 | 0.435 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.423 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.422 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.416 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.406 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.404 | Zebrafish | |
| BAG3 | BCL2-associated athanogene 3 | 0.401 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.393 | Human | |
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.391 | ||
| CPE | carboxypeptidase E | 0.385 | ||
| ZNF512B | zinc finger protein 512B | 0.378 | ||
| GDF5 | growth differentiation factor 5 | 0.367 | Human | |
| SMAD7 | SMAD family member 7 | 0.364 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.363 | ||
| EGR2 | early growth response 2 | 0.353 | Human | |
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.353 | ||
| ITGB4 | integrin, beta 4 | 0.351 | ||
| SQSTM1 | sequestosome 1 | 0.348 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.348 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.345 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.345 | ||
| HSPB1 | heat shock 27kDa protein 1 | 0.342 | ||
| HDAC7 | histone deacetylase 7 | 0.339 | ||
| EPHA7 | EPH receptor A7 | 0.337 | Human | |
| KLK8 | kallikrein-related peptidase 8 | 0.337 | Human | |
| ANGPT2 | angiopoietin 2 | 0.334 | ||
| CAV2 | caveolin 2 | 0.331 | ||
| S100A10 | S100 calcium binding protein A10 | 0.324 | Human | |
| CD44 | CD44 molecule (Indian blood group) | 0.319 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.315 | ||
| MSN | moesin | 0.314 | ||
| EFNA5 | ephrin-A5 | 0.312 | Human | |
| SKIL | SKI-like oncogene | 0.299 | ||
| ITGB5 | integrin, beta 5 | 0.298 | ||
| EPHA3 | EPH receptor A3 | 0.296 | Human | |
| COL5A1 | collagen, type V, alpha 1 | 0.291 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.289 | ||
| PRSS2 | protease, serine, 2 (trypsin 2) | 0.289 | ||
| TGFA | transforming growth factor, alpha | 0.289 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.288 | ||
| PKP3 | plakophilin 3 | 0.283 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.281 | ||
| AMOT | angiomotin | 0.277 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.277 | ||
| ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa | 0.273 | ||
| FGF10 | fibroblast growth factor 10 | 0.273 | Human | |
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.272 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.271 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.269 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.268 | Human Mouse | |
| MED25 | mediator complex subunit 25 | 0.265 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.264 | Human | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.264 | Rat | |
| SMAD1 | SMAD family member 1 | 0.262 | ||
| KLK7 | kallikrein-related peptidase 7 | 0.260 | Human | |
| POU3F2 | POU class 3 homeobox 2 | 0.258 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.256 | ||
| ATF3 | activating transcription factor 3 | 0.255 | ||
| ACTA2 | actin, alpha 2, smooth muscle, aorta | 0.255 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.254 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.251 | ||
| MEF2A | myocyte enhancer factor 2A | 0.250 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.247 | Human | |
| DSG2 | desmoglein 2 | 0.246 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.245 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.242 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.241 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.241 | Human | |
| PRKD2 | protein kinase D2 | 0.241 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.241 | ||
| EFNA1 | ephrin-A1 | 0.240 | ||
| TRIM29 | tripartite motif containing 29 | 0.234 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.230 | ||
| ACTN1 | actinin, alpha 1 | 0.230 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.230 | ||
| AHNAK | AHNAK nucleoprotein | 0.227 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.226 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.226 | ||
| PML | promyelocytic leukemia | 0.222 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.220 | ||
| ANXA5 | annexin A5 | 0.219 | Human | |
| JUP | junction plakoglobin | 0.217 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.216 | Human | |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.215 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.215 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.214 | ||
| KLK5 | kallikrein-related peptidase 5 | 0.209 | Human | |
| HP | haptoglobin | 0.208 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.205 | ||
| CD63 | CD63 molecule | 0.200 | ||
| TBX5 | T-box 5 | 0.200 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.200 | ||
| S100P | S100 calcium binding protein P | 0.199 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.197 | ||
| EPHA2 | EPH receptor A2 | 0.197 | Human Mouse | |
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.189 | ||
| NOTCH2 | notch 2 | 0.188 | Human | |
| RFWD2 | ring finger and WD repeat domain 2 | 0.188 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.187 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.187 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.186 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.182 | ||
| KRT5 | keratin 5 | 0.182 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.182 | Human | |
| AGER | advanced glycosylation end product-specific receptor | 0.179 | Rat | |
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.179 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.179 | ||
| LAMA4 | laminin, alpha 4 | 0.176 | ||
| VAC14 | Vac14 homolog (S. cerevisiae) | 0.174 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.172 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.172 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.172 | ||
| FGF7 | fibroblast growth factor 7 | 0.171 | Human | |
| GJB3 | gap junction protein, beta 3, 31kDa | 0.171 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.171 | ||
| RHOB | ras homolog gene family, member B | 0.170 | ||
| TMSB10 | thymosin beta 10 | 0.168 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.168 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.167 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.166 | ||
| SMAD2 | SMAD family member 2 | 0.164 | ||
| TBX2 | T-box 2 | 0.164 | ||
| ACTB | actin, beta | 0.162 | ||
| PRKCZ | protein kinase C, zeta | 0.160 | Human Zebrafish | |
| TAGLN2 | transgelin 2 | 0.160 | ||
| PROX1 | prospero homeobox 1 | 0.155 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.154 | ||
| APOE | apolipoprotein E | 0.154 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.153 | ||
| VCAN | versican | 0.153 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.151 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.150 | ||
| S100A2 | S100 calcium binding protein A2 | 0.150 | ||
| RET | ret proto-oncogene | 0.149 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.147 | ||
| BMP7 | bone morphogenetic protein 7 | 0.147 | Human | |
| JUND | jun D proto-oncogene | 0.146 | ||
| EMP1 | epithelial membrane protein 1 | 0.146 | ||
| SPOP | speckle-type POZ protein | 0.145 | ||
| PGF | placental growth factor | 0.145 | Human | |
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.144 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.143 | ||
| MUC1 | mucin 1, cell surface associated | 0.143 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.143 | ||
| LAD1 | ladinin 1 | 0.142 | ||
| ACVR1 | activin A receptor, type I | 0.141 | Human | |
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.138 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.135 | ||
| LDLR | low density lipoprotein receptor | 0.135 | ||
| APP | amyloid beta (A4) precursor protein | 0.134 | ||
| GAS6 | growth arrest-specific 6 | 0.134 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.133 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.133 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.133 | ||
| PAX3 | paired box 3 | 0.132 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.131 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.131 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.129 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.129 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.128 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.127 | Human | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.127 | Human | |
| HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 0.126 | ||
| BTG2 | BTG family, member 2 | 0.126 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.125 | ||
| AREG | amphiregulin | 0.125 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.125 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.125 | ||
| NFIB | nuclear factor I/B | 0.124 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.124 | ||
| EPHB3 | EPH receptor B3 | 0.124 | Human | |
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.124 | Human | |
| ILK | integrin-linked kinase | 0.123 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.121 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.119 | Zebrafish | |
| RHOG | ras homolog gene family, member G (rho G) | 0.118 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.117 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.117 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.115 | ||
| INHBB | inhibin, beta B | 0.114 | ||
| HSPB2 | heat shock 27kDa protein 2 | 0.114 | ||
| PLXNB1 | plexin B1 | 0.114 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.113 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.111 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.111 | Human Mouse | |
| DSP | desmoplakin | 0.111 | ||
| NRP2 | neuropilin 2 | 0.111 | Human | |
| LASP1 | LIM and SH3 protein 1 | 0.109 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.108 | Human | |
| THBS2 | thrombospondin 2 | 0.108 | Human | |
| PLXND1 | plexin D1 | 0.108 | Mouse | |
| ACTN4 | actinin, alpha 4 | 0.107 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.107 | ||
| DLC1 | deleted in liver cancer 1 | 0.107 | ||
| CD34 | CD34 molecule | 0.107 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.106 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.106 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.105 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.105 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.104 | Human | |
| TNXB | tenascin XB | 0.104 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.104 | ||
| RND3 | Rho family GTPase 3 | 0.103 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.103 | ||
| KRT8 | keratin 8 | 0.100 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.100 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.099 | ||
| PLXNB2 | plexin B2 | 0.099 | ||
| IRS1 | insulin receptor substrate 1 | 0.099 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.099 | ||
| BAD | BCL2-associated agonist of cell death | 0.099 | ||
| SMAD6 | SMAD family member 6 | 0.098 | ||
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.098 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.097 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.096 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.095 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.095 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.094 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.094 | ||
| NPPB | natriuretic peptide B | 0.094 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.094 | ||
| CD247 | CD247 molecule | 0.092 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.092 | Human | |
| LAMB1 | laminin, beta 1 | 0.092 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.092 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.092 | ||
| CDCP1 | CUB domain containing protein 1 | 0.091 | ||
| CNN2 | calponin 2 | 0.091 | Zebrafish | |
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.091 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.091 | ||
| NOG | noggin | 0.090 | ||
| JAG2 | jagged 2 | 0.090 | Human | |
| SP100 | SP100 nuclear antigen | 0.089 | ||
| FLNB | filamin B, beta | 0.089 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.089 | ||
| WWTR1 | WW domain containing transcription regulator 1 | 0.088 | ||
| ALB | albumin | 0.087 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.087 | ||
| AXL | AXL receptor tyrosine kinase | 0.087 | Human | |
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.087 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.087 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.086 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.085 | ||
| ANGPT1 | angiopoietin 1 | 0.085 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.085 | ||
| TNS4 | tensin 4 | 0.083 | ||
| MGP | matrix Gla protein | 0.082 | ||
| SIK1 | salt-inducible kinase 1 | 0.082 | ||
| EFNB2 | ephrin-B2 | 0.082 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.082 | ||
| KLK11 | kallikrein-related peptidase 11 | 0.082 | Human | |
| INHBA | inhibin, beta A | 0.081 | ||
| IL8 | interleukin 8 | 0.081 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.081 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.081 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.080 | ||
| PIM1 | pim-1 oncogene | 0.079 | ||
| MAP2 | microtubule-associated protein 2 | 0.079 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.079 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.079 | ||
| MVP | major vault protein | 0.078 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.077 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.077 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.077 | ||
| THBD | thrombomodulin | 0.076 | ||
| PRKCD | protein kinase C, delta | 0.075 | Human | |
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.075 | ||
| CARHSP1 | calcium regulated heat stable protein 1, 24kDa | 0.075 | ||
| TSPO | translocator protein (18kDa) | 0.075 | ||
| TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 0.075 | ||
| STK10 | serine/threonine kinase 10 | 0.075 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.075 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.074 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.074 | ||
| KRT1 | keratin 1 | 0.074 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.074 | ||
| APOA2 | apolipoprotein A-II | 0.073 | ||
| NOTCH4 | notch 4 | 0.073 | Human | |
| SOX11 | SRY (sex determining region Y)-box 11 | 0.073 | Human | |
| MYOCD | myocardin | 0.072 | ||
| MYOD1 | myogenic differentiation 1 | 0.072 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.072 | ||
| TUBB6 | tubulin, beta 6 | 0.072 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.071 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.071 | ||
| DST | dystonin | 0.071 | ||
| CALD1 | caldesmon 1 | 0.071 | ||
| S1PR1 | sphingosine-1-phosphate receptor 1 | 0.070 | ||
| PDE10A | phosphodiesterase 10A | 0.070 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.070 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.070 | ||
| RARB | retinoic acid receptor, beta | 0.070 | ||
| PRRX1 | paired related homeobox 1 | 0.070 | ||
| BMP4 | bone morphogenetic protein 4 | 0.069 | ||
| PXN | paxillin | 0.069 | ||
| RARG | retinoic acid receptor, gamma | 0.069 | ||
| PDCD6 | programmed cell death 6 | 0.069 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.069 | ||
| FOXF1 | forkhead box F1 | 0.068 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.068 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.068 | ||
| AMOTL1 | angiomotin like 1 | 0.068 | Human Mouse | |
| DSG3 | desmoglein 3 | 0.067 | ||
| APC | adenomatous polyposis coli | 0.067 | ||
| CDSN | corneodesmosin | 0.067 | ||
| LAMC2 | laminin, gamma 2 | 0.067 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.065 | ||
| EPHA4 | EPH receptor A4 | 0.065 | Human | |
| EPHB6 | EPH receptor B6 | 0.065 | Human | |
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.065 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.065 | Mouse | |
| STAB1 | stabilin 1 | 0.065 | ||
| KITLG | KIT ligand | 0.065 | ||
| PDS5B | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) | 0.064 | ||
| MYO1C | myosin IC | 0.064 | ||
| EPHB4 | EPH receptor B4 | 0.064 | ||
| SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 | 0.064 | ||
| HTRA1 | HtrA serine peptidase 1 | 0.064 | ||
| PLEC | plectin | 0.063 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.063 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.063 | ||
| PLAT | plasminogen activator, tissue | 0.063 | ||
| TRPM7 | transient receptor potential cation channel, subfamily M, member 7 | 0.063 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.063 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.063 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.063 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.063 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.063 | ||
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.062 | ||
| MAPT | microtubule-associated protein tau | 0.062 | ||
| IER3 | immediate early response 3 | 0.062 | ||
| PTRF | polymerase I and transcript release factor | 0.062 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.062 | ||
| FOSL2 | FOS-like antigen 2 | 0.062 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.062 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.062 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.061 | ||
| ITGA6 | integrin, alpha 6 | 0.061 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.061 | ||
| AKAP2 | A kinase (PRKA) anchor protein 2 | 0.061 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.061 | ||
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.061 | Human | |
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.061 | ||
| PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.061 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.061 | ||
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.061 | ||
| DCN | decorin | 0.060 | ||
| ARHGEF40 | Rho guanine nucleotide exchange factor (GEF) 40 | 0.060 | ||
| SDC2 | syndecan 2 | 0.060 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.060 | ||
| ZCCHC24 | zinc finger, CCHC domain containing 24 | 0.060 | ||
| PRKAR1B | protein kinase, cAMP-dependent, regulatory, type I, beta | 0.059 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.059 | ||
| SH2D3C | SH2 domain containing 3C | 0.059 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.058 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.058 | ||
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.058 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.058 | Mouse | |
| EFNB3 | ephrin-B3 | 0.058 | Human | |
| ZNF71 | zinc finger protein 71 | 0.058 | ||
| EVPL | envoplakin | 0.058 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.058 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.058 | ||
| MKL2 | MKL/myocardin-like 2 | 0.058 | ||
| GPC3 | glypican 3 | 0.058 | ||
| PHLDB1 | pleckstrin homology-like domain, family B, member 1 | 0.058 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.057 | ||
| EDN1 | endothelin 1 | 0.057 | ||
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.057 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.057 | ||
| BMP8A | bone morphogenetic protein 8a | 0.057 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.056 | ||
| NDUFA4L2 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 | 0.056 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.056 | ||
| PTHLH | parathyroid hormone-like hormone | 0.056 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.056 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.056 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.055 | ||
| PRKAR2B | protein kinase, cAMP-dependent, regulatory, type II, beta | 0.055 | ||
| CAP1 | CAP, adenylate cyclase-associated protein 1 (yeast) | 0.055 | ||
| C1orf116 | chromosome 1 open reading frame 116 | 0.055 | ||
| MYADM | myeloid-associated differentiation marker | 0.055 | ||
| APOC1 | apolipoprotein C-I | 0.055 | ||
| AKIP1 | A kinase (PRKA) interacting protein 1 | 0.054 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.054 | ||
| KRT17 | keratin 17 | 0.054 | ||
| FRZB | frizzled-related protein | 0.054 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.053 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.053 | ||
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 0.053 | Mouse | |
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.053 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.052 | ||
| TNC | tenascin C | 0.052 | ||
| FZD2 | frizzled homolog 2 (Drosophila) | 0.052 | ||
| RGL1 | ral guanine nucleotide dissociation stimulator-like 1 | 0.052 | ||
| DCBLD2 | discoidin, CUB and LCCL domain containing 2 | 0.052 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.052 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.051 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.051 | ||
| CD248 | CD248 molecule, endosialin | 0.051 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.051 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.051 | ||
| NCAM1 | neural cell adhesion molecule 1 | 0.051 | ||
| HR | hairless homolog (mouse) | 0.050 | ||
| ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.050 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.050 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.050 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.050 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.050 | ||
| SULF1 | sulfatase 1 | 0.050 | ||
| GLI1 | GLI family zinc finger 1 | 0.050 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.049 | ||
| VWF | von Willebrand factor | 0.049 | ||
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.049 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.049 | ||
| SPRR1A | small proline-rich protein 1A | 0.049 | ||
| MEF2C | myocyte enhancer factor 2C | 0.049 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.049 | ||
| PTPRG | protein tyrosine phosphatase, receptor type, G | 0.049 | ||
| MMP19 | matrix metallopeptidase 19 | 0.049 | ||
| PRKCQ | protein kinase C, theta | 0.049 | Human | |
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.049 | ||
| ZNF331 | zinc finger protein 331 | 0.048 | ||
| PBX1 | pre-B-cell leukemia homeobox 1 | 0.048 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.048 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.048 | ||
| KLK6 | kallikrein-related peptidase 6 | 0.047 | Human | |
| RXRA | retinoid X receptor, alpha | 0.047 | Human | |
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.047 | ||
| HOXB13 | homeobox B13 | 0.047 | ||
| SLA | Src-like-adaptor | 0.047 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.047 | ||
| LATS1 | LATS, large tumor suppressor, homolog 1 (Drosophila) | 0.047 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.047 | ||
| CD151 | CD151 molecule (Raph blood group) | 0.047 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.046 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.046 | Human | |
| HDAC6 | histone deacetylase 6 | 0.046 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.045 | ||
| KLF7 | Kruppel-like factor 7 (ubiquitous) | 0.045 | Human | |
| DAXX | death-domain associated protein | 0.045 | ||
| GREM1 | gremlin 1 | 0.045 | Mouse | |
| TACSTD2 | tumor-associated calcium signal transducer 2 | 0.045 | ||
| S100A12 | S100 calcium binding protein A12 | 0.045 | Human | |
| SH2D3A | SH2 domain containing 3A | 0.045 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.045 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.044 | ||
| RND1 | Rho family GTPase 1 | 0.044 | ||
| PRKCB | protein kinase C, beta | 0.044 | Human | |
| STC1 | stanniocalcin 1 | 0.044 | ||
| ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | 0.044 | ||
| FOXC1 | forkhead box C1 | 0.043 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.043 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.043 | ||
| KRT14 | keratin 14 | 0.043 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.043 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.043 | ||
| EPHB2 | EPH receptor B2 | 0.043 | Human | |
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.043 | ||
| PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.043 | ||
| TSPAN4 | tetraspanin 4 | 0.043 | ||
| PLTP | phospholipid transfer protein | 0.043 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.043 | ||
| FHL2 | four and a half LIM domains 2 | 0.043 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.043 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.042 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.042 | ||
| TTR | transthyretin | 0.042 | ||
| EPHB1 | EPH receptor B1 | 0.042 | Human | |
| FOXP3 | forkhead box P3 | 0.042 | ||
| SLPI | secretory leukocyte peptidase inhibitor | 0.042 | ||
| AKAP11 | A kinase (PRKA) anchor protein 11 | 0.042 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.042 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.042 | ||
| PLAU | plasminogen activator, urokinase | 0.042 | ||
| CLDN5 | claudin 5 | 0.042 | ||
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.041 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.041 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.041 | ||
| GJB5 | gap junction protein, beta 5, 31.1kDa | 0.041 | ||
| MYO10 | myosin X | 0.041 | ||
| TG | thyroglobulin | 0.041 | ||
| S100A7 | S100 calcium binding protein A7 | 0.041 | ||
| LAMB3 | laminin, beta 3 | 0.041 | ||
| NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.041 | ||
| ANXA4 | annexin A4 | 0.041 | ||
| KLF13 | Kruppel-like factor 13 | 0.040 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.040 | ||
| DAPK1 | death-associated protein kinase 1 | 0.040 | ||
| MCAM | melanoma cell adhesion molecule | 0.040 | ||
| TSC22D4 | TSC22 domain family, member 4 | 0.040 | ||
| FYB | FYN binding protein | 0.040 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.040 | ||
| SASH1 | SAM and SH3 domain containing 1 | 0.040 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.040 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.040 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.040 | ||
| EDNRB | endothelin receptor type B | 0.040 | ||
| WNT6 | wingless-type MMTV integration site family, member 6 | 0.040 | ||
| CD99 | CD99 molecule | 0.040 | ||
| RRBP1 | ribosome binding protein 1 homolog 180kDa (dog) | 0.040 | ||
| APOC3 | apolipoprotein C-III | 0.040 | ||
| HAS2 | hyaluronan synthase 2 | 0.039 | ||
| RUNX2 | runt-related transcription factor 2 | 0.039 | ||
| TCF21 | transcription factor 21 | 0.039 | ||
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.039 | ||
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.039 | ||
| NBR1 | neighbor of BRCA1 gene 1 | 0.039 | ||
| CLU | clusterin | 0.039 | ||
| ITGB8 | integrin, beta 8 | 0.039 | ||
| PLK2 | polo-like kinase 2 | 0.039 | ||
| VCL | vinculin | 0.039 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.039 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.039 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.038 | ||
| PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.038 | ||
| SYK | spleen tyrosine kinase | 0.038 | Zebrafish | |
| ACVR2B | activin A receptor, type IIB | 0.038 | ||
| BCR | breakpoint cluster region | 0.038 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.038 | ||
| CRCT1 | cysteine-rich C-terminal 1 | 0.038 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.038 | ||
| PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.038 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.038 | ||
| MECOM | MDS1 and EVI1 complex locus | 0.038 | ||
| IRS2 | insulin receptor substrate 2 | 0.038 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.038 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.038 | ||
| DSG1 | desmoglein 1 | 0.037 | ||
| PER1 | period homolog 1 (Drosophila) | 0.037 | ||
| AEBP1 | AE binding protein 1 | 0.037 | ||
| EMCN | endomucin | 0.037 | ||
| ANXA11 | annexin A11 | 0.037 | Human | |
| PLXDC1 | plexin domain containing 1 | 0.037 | ||
| MYLK | myosin light chain kinase | 0.037 | ||
| MYOF | myoferlin | 0.037 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.037 | ||
| RGS4 | regulator of G-protein signaling 4 | 0.037 | ||
| CD37 | CD37 molecule | 0.037 | ||
| GPSM3 | G-protein signaling modulator 3 | 0.037 | ||
| EFNB1 | ephrin-B1 | 0.037 | Human | |
| DUSP6 | dual specificity phosphatase 6 | 0.037 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.037 | ||
| STAG1 | stromal antigen 1 | 0.037 | ||
| BCAM | basal cell adhesion molecule (Lutheran blood group) | 0.036 | ||
| ACAN | aggrecan | 0.036 | ||
| CD2 | CD2 molecule | 0.036 | ||
| EGF | epidermal growth factor | 0.036 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.036 | ||
| MSX1 | msh homeobox 1 | 0.036 | ||
| ZFP36L2 | zinc finger protein 36, C3H type-like 2 | 0.036 | ||
| PCDH7 | protocadherin 7 | 0.036 | ||
| LPL | lipoprotein lipase | 0.036 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.036 | ||
| MAST1 | microtubule associated serine/threonine kinase 1 | 0.035 | ||
| KLK3 | kallikrein-related peptidase 3 | 0.035 | Human | |
| SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) | 0.035 | ||
| PTCH1 | patched 1 | 0.035 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.035 | ||
| FGF6 | fibroblast growth factor 6 | 0.035 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.035 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.035 | ||
| ELAVL3 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) | 0.035 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.035 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.035 | ||
| POSTN | periostin, osteoblast specific factor | 0.035 | ||
| C1orf106 | chromosome 1 open reading frame 106 | 0.035 | ||
| GPRC5B | G protein-coupled receptor, family C, group 5, member B | 0.035 | ||
| HEG1 | HEG homolog 1 (zebrafish) | 0.035 | ||
| HNF1A | HNF1 homeobox A | 0.035 | ||
| GPM6B | glycoprotein M6B | 0.035 | ||
| LCN2 | lipocalin 2 | 0.034 | ||
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.034 | ||
| ASRGL1 | asparaginase like 1 | 0.034 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.034 | ||
| LHFP | lipoma HMGIC fusion partner | 0.034 | ||
| EML3 | echinoderm microtubule associated protein like 3 | 0.034 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.034 | ||
| HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A | 0.034 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.034 | ||
| EPOR | erythropoietin receptor | 0.034 | ||
| SIX3 | SIX homeobox 3 | 0.034 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.034 | ||
| GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.034 | ||
| KRT16 | keratin 16 | 0.034 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.034 | ||
| SMO | smoothened homolog (Drosophila) | 0.034 | ||
| ZNF746 | zinc finger protein 746 | 0.034 | ||
| CHRD | chordin | 0.034 | ||
| ALS2CL | ALS2 C-terminal like | 0.033 | ||
| GFAP | glial fibrillary acidic protein | 0.033 | ||
| TYRP1 | tyrosinase-related protein 1 | 0.033 | ||
| MT2A | metallothionein 2A | 0.033 | ||
| GDF6 | growth differentiation factor 6 | 0.033 | Human | |
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.033 | ||
| RHOC | ras homolog gene family, member C | 0.033 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.033 | ||
| LDB2 | LIM domain binding 2 | 0.033 | ||
| SOX4 | SRY (sex determining region Y)-box 4 | 0.033 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.033 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.033 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.033 | ||
| NNAT | neuronatin | 0.033 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.033 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.033 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.033 | ||
| PLEKHO1 | pleckstrin homology domain containing, family O member 1 | 0.033 | ||
| OSMR | oncostatin M receptor | 0.033 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.033 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.033 | ||
| MPDZ | multiple PDZ domain protein | 0.033 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.033 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.033 | ||
| FOXA2 | forkhead box A2 | 0.032 | ||
| PCDH17 | protocadherin 17 | 0.032 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.032 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.032 | ||
| PAEP | progestagen-associated endometrial protein | 0.032 | ||
| ZFPM2 | zinc finger protein, multitype 2 | 0.032 | ||
| ELANE | elastase, neutrophil expressed | 0.032 | ||
| DBN1 | drebrin 1 | 0.032 | ||
| CUL2 | cullin 2 | 0.032 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.032 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.032 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.032 | ||
| ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 0.032 | ||
| FOXD3 | forkhead box D3 | 0.032 | ||
| CSTA | cystatin A (stefin A) | 0.032 | ||
| GATA6 | GATA binding protein 6 | 0.032 | Human | |
| AMOTL2 | angiomotin like 2 | 0.032 | Human | |
| EXT1 | exostosin 1 | 0.032 | ||
| IVL | involucrin | 0.032 | ||
| IRX4 | iroquois homeobox 4 | 0.032 | ||
| PLP1 | proteolipid protein 1 | 0.032 | ||
| ADD3 | adducin 3 (gamma) | 0.032 | ||
| C7 | complement component 7 | 0.032 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.032 | ||
| MEIS1 | Meis homeobox 1 | 0.031 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.031 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.031 | ||
| ARL4C | ADP-ribosylation factor-like 4C | 0.031 | ||
| TBX1 | T-box 1 | 0.031 | ||
| IL1B | interleukin 1, beta | 0.031 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.031 | ||
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.031 | ||
| EZR | ezrin | 0.031 | ||
| WWC1 | WW and C2 domain containing 1 | 0.031 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.031 |